Bausch + Lomb Corporation Common Shares (NY:BLCO)

16.56 -0.07 (-0.42%)

Streaming Delayed Price Updated: 2:27 PM EDT, Jun 30, 2026 Add to My Watchlist

Price and Volume

Volume	201,429
Open	16.35
Bid (Size)	16.56 (100)
Ask (Size)	16.59 (500)
Prev. Close	16.63
Today's Range	16.32 - 16.62
52wk Range	12.41 - 18.91
Shares Outstanding	353,800,000
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

3 Small-Cap Stocks We Steer Clear Of

Today 0:35 EDT

Many small-cap stocks have limited Wall Street coverage, giving savvy investors the chance to act before everyone else catches on. But the flip side is that ...

Via StockStory

1 Stock Under $50 to Own for Decades and 2 We Turn Down

June 25, 2026

Stocks in the $10-50 range offer a sweet spot between affordability and stability as they’re typically more established than penny stocks. But their headline...

Via StockStory

Performance

YTD	-0.1%	-0.1%
1 Month	+7.6%	+7.6%
3 Month	+8.5%	+8.5%
6 Month	-3.4%	-3.4%
1 Year	+27.3%	+27.3%

More News

Bausch + Lomb Launches Blink® Triple Care Preservative Free Lubricant Eye Drops in the United States

June 01, 2026

From Bausch + Lomb Corporation

Via Business Wire

Bausch + Lomb to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference

May 21, 2026

From Bausch + Lomb Corporation

Via Business Wire

Bausch + Lomb Corp (NYSE:BLCO) Beats Q1 Estimates, Raises Full-Year Guidance ↗

April 29, 2026

Via Chartmill

Bausch + Lomb Announces 2026 Annual Meeting of Shareholder Results

May 20, 2026

From Bausch + Lomb Corporation

Via Business Wire

Medical Devices & Supplies - Specialty Stocks Q1 Teardown: Bausch + Lomb (NYSE:BLCO) Vs The Rest

May 19, 2026

Via StockStory

Bausch + Lomb Launches PreserVision AREDS3™ Eye Vitamins in the United States

May 19, 2026

From Bausch + Lomb Corporation

Via Business Wire

3 Profitable Stocks We’re Skeptical Of

May 18, 2026

Via StockStory

Bausch + Lomb Launches Bi-Blade+™ Dual-Port Vitrectomy Cutter in Europe

May 07, 2026

From Bausch + Lomb Corporation

Via Business Wire

Bausch + Lomb Announces Second R&D “Teach-in” Webinar

May 06, 2026

From Bausch + Lomb Corporation

Via Business Wire

Bausch + Lomb (BLCO) Q1 2026 Earnings Transcript ↗

April 30, 2026

Via The Motley Fool

Bausch + Lomb to Feature More Than 40 Scientific Studies at the 2026 Association for Research in Vision and Ophthalmology Annual Meeting

April 30, 2026

From Bausch + Lomb Corporation

Via Business Wire

Bausch + Lomb (NYSE:BLCO) Posts Better-Than-Expected Sales In Q1 CY2026

April 29, 2026

Via StockStory

Bausch + Lomb Announces First-Quarter 2026 Results, Raises Guidance Based on Strong Performance and Positive Outlook

April 29, 2026

From Bausch + Lomb Corporation

Via Business Wire

Bausch + Lomb (BLCO) Q1 Earnings Report Preview: What To Look For

April 27, 2026

Via StockStory

Bausch + Lomb Announces Published Review Examining the Role of B Vitamins in Reducing Risk and Progression of Age-Related Macular Degeneration

April 23, 2026

From Bausch + Lomb Corporation

Via Business Wire

Bausch + Lomb Releases 2025 Sustainability Impact Report

April 22, 2026

From Bausch + Lomb Corporation

Via Business Wire

Bausch Lomb BLCO Q2 2025 Earnings Transcript ↗

April 21, 2026

Via The Motley Fool

Bausch + Lomb (BLCO) Q3 2025 Earnings Transcript ↗

April 21, 2026

Via The Motley Fool

Bausch + Lomb (BLCO) Q4 2025 Earnings Transcript ↗

April 21, 2026

Via The Motley Fool

Bausch + Lomb Reports Nearly 725,000 Pounds of Contact Lens, Lens Care and Eye Care Materials Collected and Recycled Through ONE By ONE Recycling Program

April 16, 2026

From Bausch + Lomb Corporation

Via Business Wire

3 Cash-Burning Stocks We Keep Off Our Radar

April 10, 2026

Via StockStory

Bausch + Lomb Receives FDA 510(k) Clearance for Bi-Blade+™ Dual-Port Vitrectomy Cutter and Adaptive Fluidics™ Advanced Update

April 08, 2026

From Bausch + Lomb Corporation

Via Business Wire

1 Healthcare Stock with Solid Fundamentals and 2 We Brush Off

April 08, 2026

Via StockStory

Frequently Asked Questions

Is Bausch + Lomb Corporation Common Shares publicly traded?

Yes, Bausch + Lomb Corporation Common Shares is publicly traded.

What exchange does Bausch + Lomb Corporation Common Shares trade on?

Bausch + Lomb Corporation Common Shares trades on the New York Stock Exchange

What is the ticker symbol for Bausch + Lomb Corporation Common Shares?

The ticker symbol for Bausch + Lomb Corporation Common Shares is BLCO on the New York Stock Exchange

What is the current price of Bausch + Lomb Corporation Common Shares?

The current price of Bausch + Lomb Corporation Common Shares is 16.56

When was Bausch + Lomb Corporation Common Shares last traded?

The last trade of Bausch + Lomb Corporation Common Shares was at 06/30/26 02:27 PM ET

What is the market capitalization of Bausch + Lomb Corporation Common Shares?

The market capitalization of Bausch + Lomb Corporation Common Shares is 5.86B

How many shares of Bausch + Lomb Corporation Common Shares are outstanding?

Bausch + Lomb Corporation Common Shares has 6B shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.